Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 16, 2004New England Journal of Medicine

B Cells, Be Gone — B-Cell Depletion in the Treatment of Rheumatoid Arthritis

View Full Paper
Ask AI
Bookmark
Share

Authors

GTGeorge C. TsokosUnifor

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

George C. Tsokos (2004) studied this question.

synapsesocial.com/papers/6a910c69d2f2d69b3a745d6dhttps://doi.org/10.1056/nejmp048114
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis2004 · 2,648 citations
  2. 2Rituximab therapy and autoimmune disorders: Prospects for anti–B cell therapy2003 · 367 citations
  3. 3Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes2001 · 525 citations
  4. 4The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials1993 · 1,652 citations